Corrigendum to "Calcium channels, neuromuscular synaptic transmission and neurological diseases" [J. Neuroimmunol. 201-202, 136-144, 2008] (DOI:10.1016/j.jneuroim.2008.06.031);Calcium channels, neuromuscular synaptic transmission and neurological diseases

Journal of Neuroimmunology

Volumn 201-202, Issue C, 2008, Pages 136-144

  Urbano, Francisco J ^a   Pagani, Mario R ^a   Uchitel, Osvaldo D ^a  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

Author keywords

Autoinmune Lambert Eaton Syndrome; Calcium channels; Knock in; Knock out; L type calcium channels; Neuromuscular junction; P Q type calcium channels

Indexed keywords

CALCIUM CHANNEL CAV2.1; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; NIFEDIPINE; NITRENDIPINE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

EATON LAMBERT SYNDROME; HUMAN; NEUROLOGIC DISEASE; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SYNAPTIC TRANSMISSION;

EID: 51649108014     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.10.001     Document Type: Erratum

References (109)

1. Adams B.A., and Beam K.G. Muscular dysgenesis in mice: a model system for studying excitation-contraction coupling. Faseb J. 4 (1990) 2809-2816
2. Arsac C., Raymond C., Martin-Moutot N., Dargent B., Couraud F., Pouget J., and Seagar M. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum. Ann. Neurol. 40 5 (1996) 695-700
3. Atchison W.D. Dihydropyridine-sensitive and -insensitive components of acetylcholine release from rat motor nerve terminals. J. Pharmacol. Exp. Ther. 251 (1989) 672-678
4. Bennett M.K., Calakos N., Kreiner T., and Scheller R.H. Synaptic vesicle membrane proteins interact to form a multimeric complex. J Cell Biol. 116 3 (1992) 761-775
5. Bennett M.K., Calakos N., and Scheller R.H. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 257 5067 (1992) 255-259
6. Bernard G., and Shevell M.I. Channelopathies: a review. Pediatr. Neurol. 38 (2008) 73-85
7. Bidaud I., Mezghrani A., Swayne L.A., Monteil A., and Lory P. Voltage-gated calcium channels in genetic diseases. Biochim Biophys Acta 1763 11 (2006) 1169-1174
8. Birnbaumer L., Campbell K.P., Catterall W.A., Harpold M.M., Hofmann F., Horne W.A., Mori Y., Schwartz A., Snutch T.P., Tanabe T., Birnbaumer L., Tsien R.W., and Catterall W.A. The naming of voltage-gated calcium channels. Neuron 13 (1994) 505-506
9. Birnbaumer L., Qin N., Olcese R., Tareilus E., Platano D., Costantin J., and Stefani E. Structures and functions of calcium channel beta subunits. J. Bioenerg. Biomembr. 30 (1998) 357-375
10. Blum J.W., and Baumrucker C.R. Insulin-like growth factors (IGFs), IGF binding proteins, and other endocrine factors in milk: role in the newborn. Adv. Exp. Med. Biol. 606 (2008) 397-422 Review
11. Buchwald B., Ahangari R., Weishaupt A., and Toyka K.V. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins. Muscle Nerve 31 (2005) 487-494
12. Burger A., Voges D., Demange P., Perez C.R., Huber R., and Berendes R. Structural and electrophysiological analysis of annexin V mutants. Mutagenesis of human annexin V, an in vitro voltage-gated calcium channel, provides information about the structural features of the ion pathway, the voltage sensor and the ion selectivity filter. J. Mol. Biol. 237 (1994) 479-499
13. Burgess D.L., and Noebels J.L. Voltage-dependent calcium channel mutations in neurological disease. Ann. N.Y. Acad. Sci. 868 (1999) 199-212
14. Catterall W.A. Excitation-contraction coupling in vertebrate skeletal muscle: a tale of two calcium channels. Cell 64 (1991) 871-874
15. 2+ channels and their role in neurotransmitter release. Cell Calcium. 24 5-6 (1998) 307-323
16. 2+ channels. Annu. Rev. Cell Dev. Biol. 16 (2000) 521-555
17. Chandy K.G., and Gutman G.A. Nomenclature for mammalian potassium channel genes. Trends Pharmacol. Sci. 14 (1993) 434
18. Chemin J., Monteil A., Bourinet E., Nargeot J., and Lory P. Alternatively spliced alpha(1G) (Ca(V)3.1) intracellular loops promote specific T-type Ca(2+) channel gating properties. Biophys. J. 80 (2001) 1238-1250
19. Cull-Candy S.G., Miledi R., and Uchitel O.D. Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates. Nature 286 5772 (1980) 500-502
20. Cull-Candy S.G., Miledi R., Trautmann A., and Uchitel O.D. On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates. J. Physiol. (Lond.) 299 (1980) 621-638
21. Day N.C., Wood S.J., Ince P.G., Volsen S.G., Smith W., Slater C.R., and Shaw P.J. Differential localization of voltage-dependent calcium channel α1 subunits at the human and rat neuromuscular junction. J. Neurosci. 17 (1997) 6226-6235
22. Delbono O., García J., Appel S.H., and Stefani E. Calcium current and charge movement of mammalian muscle: action of amyotrophic lateral sclerosis immunoglobulins. J. Physiol. (Lond.) 444 (1991) 723-742
23. De Luca A., Rand M.J., Reid J.J., and Story D.F. Differential sensitivities of avian and mammalian neuromuscular junctions to inhibition of cholinergic transmission by ω-conotoxin GVIA. Toxicon 29 (1991) 311-320
24. Depetris R.S., Nudler S.I., Uchitel O.D., and Urbano F.J. Altered synaptic synchrony in motor nerve terminals lacking P/Q-calcium channels. Synapse 62 6 (2008) 466-471
25. Dolphin A.C. Beta subunits of voltage-gated calcium channels. J. Bioenerg. Biomembranes 35 (2003) 599-620
26. Eaton L.M., and Lambert E.H. Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. J. Am. Med. Assoc. 163 13 (1957) 1117-1124
27. Elmqvist D., and Lambert E.H. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin. Proc. 43 10 (1968) 689-713
28. Engel A.G., Nagel A., Fukuoka T., Fukunaga H., Osame M., Lang B., Newsom-Davis J., Vincent A., Wray D.W., and Peers C. Motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome. Morphologic evidence for depletion and that the depletion is mediated by autoantibodies. Ann. N. Y. Acad. Sci. 560 (1989) 278-290
29. Ertel E.A., Campbell K.P., Harpold M.M., Hofmann F., Mori Y., Perez-Reyes E., Schwartz A., Snutch T.P., Tanabe T., Birnbaumer L., Tsien R.W., and Catterall W.A. Nomenclature of voltage-gated calcium channels. Neuron 25 (2000) 533-535
30. Estes P.S., Roos J., van der Bliek A., Kelly R.B., Krishnan K.S., and Ramaswami M. Traffic of dynamin within individual Drosophila synaptic boutons relative to compartment-specific markers. J. Neurosci. 16 (1996) 5443-5456
31. Fletcher C.F., Lutz C.M., O'Sullivan T.N., Shaughnessy J.D., Hawkes R., Frankel W.N., Copeland N.G., and Jenkins N.A. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87 (1996) 607-617
32. Flink M.T., and Atchison W.D. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission. J. Physiol. (Lond.) 543 (2002) 567-576
33. 2+ channelopathies. J. Bioenerg. Biomem. 35 6 (2003) 697-718
34. Fukunaga H., Engel A.G., Lang B., Newsom-Davis J., and Vincent A. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc. Natl. Acad. Sci. U.S.A. 80 24 (1983) 7636-7640
35. Fukuoka T., Engel A.G., Lang B., Newsom-Davis J., Prior C., and Wray D.W. Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones. Ann. Neurol. 22 2 (1987) 193-199
36. Fukuoka T., Engel A.G., Lang B., Newsom-Davis J., and Vincent A. Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate. Ann. Neurol. 22 2 (1987) 200-211
37. Guida S., Trettel F., Pagnutti S., Mantuano E., Tottene A., Veneziano L., Fellin T., Spadaro M., Stauderman K., Williams M., Volsen S., Ophoff R., Frants R., Jodice C., Frontali M., and Pietrobon D. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am. J. Hum. Genet. 68 3 (2001) 759-764
38. 2+ channel diversity. Annu. Rev. Neurosci. 17 (1994) 399-418
39. Inchauspe C.G., Forsythe I.D., and Uchitel O.D. Changes in synaptic transmission properties due to the expression of N-type calcium channels at the calyx of Held synapse of mice lacking P/Q-type calcium channels. J. Physiol. (Lond.) 584 (2007) 835-851
40. Inchauspe C.G., Martini F.J., Forsythe I.D., and Uchitel O.D. Functional compensation of P/Q by N-type channels blocks short-term plasticity at the calyx of held presynaptic terminal. J. Neurosci. 24 46 (2004) 10379-10383
41. Jablecki C. Lambert-Eaton myasthenic syndrome. Muscle Nerve. 7 3 (1984) 250-257
42. Jahnsen H., and Llinás R. Electrophysiological properties of guinea-pig thalamic neurones: an in vitro study. J. Physiol. (Lond.) 349 (1984) 205-226
43. Jahnsen H., and Llinás R. Ionic basis for the electro-responsiveness and oscillatory properties of guinea-pig thalamic neurones in vitro. J. Physiol. (Lond.) 349 (1984) 227-247
44. 2+ channel mutations associated with episodic ataxia type 2. Am. J. Physiol. Cell Physiol. 290 4 (2006) C1209-C1220
45. 2+ channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the α1A-subunit. Proc. Natl. Acad. Sci. U.S.A. 21 (1999) 15245-15250
46. Kaja S., van de Ven R.C., Broos L.A., Veldman H., van Dijk J.G., Verschuuren J.J., Frants R.R., Ferrari M.D., van den Maagdenberg A.M., and Plomp J.J. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience 135 1 (2005) 81-95
47. Kaja S., Van De Ven R.C., Frants R.R., Ferrari M.D., Van Den Maagdenberg A.M., and Plomo J.J. Reduced ACh release at neuromuscular synapses of heterozygous leaner Ca(v)2.1-mutant mice. Synapse 62 5 (2008) 337-344
48. Kaja S., Van de Ven R.C., Ferrari M.D., Frants R.R., Van den Maagdenberg A.M., and Plomp J.J. Compensatory contribution of Cav2.3 channels to acetylcholine release at the neuromuscular junction of Tottering mice. J. Neurophysiol. 95 (2006) 2698-2704
49. Kaja S., van de Ven R.C., van Dijk J.G., Verschuuren J.J., Arahata K., Frants R.R., Ferrari M.D., van den Maagdenberg A.M., and Plomp J.J. Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya. Eur. J. Neurosci. 25 7 (2007) 2009-2020
50. Kanumilli S., Tringham E.W., Payne C.E., Dupere J.R., Venkateswarlu K., and Usowicz M.M. Alternative splicing generates a smaller assortment of CaV2.1 transcripts in cerebellar Purkinje cells than in the cerebellum. Physiol. Genomics 24 2 (2006) 86-96
51. Katz E., Ferro P.A., Weisz G., and Uchitel O.D. Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction. J. Physiol. (Lond.) 497 (1996) 687-697
52. Katz B., and Miledi R. The effect of calcium on acetylcholine release from motor nerve terminals. Proc. R. Soc. Lond. B. Biol. Sci. 161 (1965) 496-503
53. Lang B., Newsom-Davis J., Wray D., Vincent A., and Murray N. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 2 8240 (1981) 224-226
54. Lang B., Newsom-Davis J., Peers C., Prior C., and Wray D.W. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. J Physiol. 390 (1987) 257-270
55. Lambert E.H., and Elmqvist D. Quantal components of end-plate potentials in the myasthenic syndrome. Ann. N. Y. Acad. Sci. 183 (1971) 183-199
56. Lennon V.A., Kryzer T.J., Griesmann G.E., O'Suilleabhain P.E., Windebank A.J., Woppmann A., Miljanich G.P., and Lambert E.H. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N. Engl. J. Med. 332 (1995) 1467-1474
57. Llinas R.R., Choi S., Urbano F.J., and Shin H.S. Gamma-band deficiency and abnormal thalamocortical activity in P/Q-type channel mutant mice. Proc. Natl. Acad. Sci. U.S.A. 103 45 (2007) 17819-17824
58. Llinás R., and Jahnsen H. Electrophysiology of mammalian thalamic neurones in vitro. Nature 297 5865 (1982) 406-408
59. 2+ channels in the mammalian central nervous system. Trends Neurosci. 15 9 (1992) 351-355
60. Losavio A., and Muchnik S. Spontaneous acetylcholine release in mammalian neuromuscular junctions. Am. J. Physiol. 273 6 Pt 1 (1997) C1835-1841
61. Mallart A. Electric current flow inside perineurial sheaths of mouse motor nerves. J. Physiol. (Lond.) 368 (1985) 565-575
62. McKeown L., Robinson P., and Jones O.T. Molecular basis of inherited calcium channelopathies: role of mutations in pore-forming subunits. Acta Pharmacol. Sin. 27 (2006) 799-812
63. Mori Y., Friedrich T., Kim M.S., Mikami A., Nakai J., Ruth P., Bosse E., Hofmann F., Flockerzi V., Furuichi T., Mikoshiba K., Imoto K., Tanabe T., and Numa S. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 350 (1991) 398-402
64. Motomura M., Johnston I., Lang B., Vincent A., and Newsom-Davis J. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J. Neurol. Neurosurg. Psychiatry 58 1 (1995) 85-87
65. Nowycky M.C., Fox A.P., and Tsien R.W. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316 6027 (1985) 440-443
66. V2.2 calcium channels functional expression at rat levator ani neuromuscular junction. Neuroscience 134 (2005) 817-826
67. O'Neill J.H., Murray N.M., and Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 111 Pt 3 (1988) 577-596
68. 2+ channel gene CACNL1A4. Cell 87 (1996) 543-552
69. 2+ channel knockout mouse. Neuroscience 123 (2004) 75-85
70. 2+ channels. J. Pharmacol. Exp. Ther. 319 (2006) 1009-1020
71. Piedras-Rentería E.S., Pyle J.L., Diehn M., Glickfeld L.L., Harata N.C., Cao Y., Kavalali E.T., Brown P.O., and Tsien R.W. Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway. Proc. Natl. Acad. Sci. U.S.A. 101 10 (2004) 3609-3614
72. Pinto A., Gillard S., Moss F., Whyte K., Brust P., Williams M., Stauderman K., Harpold M., Lang B., Newsom-Davis J., Bleakman D., Lodge D., and Boot J. Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons. Proc. Natl. Acad. Sci. U.S.A. 95 14 (1998) 8328-8333
73. Pinto A., Iwasa K., Newland C., Newsom-Davis J., and Lang B. The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels. Muscle Nerve. 25 5 (2002) 715-724
74. Perez-Reyes E. Molecular physiology of low-voltage-activated t-type calcium channels. Physiol. Rev. 83 (2003) 117-161
75. Perissinotti P.P., Giugovaz-Tropper B., and Uchitel O.D. L-type calcium channels are involved in fast endocytosis at the mouse neuromuscular junction. Eur. J. Neurosci. 27 6 (2008) 1333-1344
76. Pietrobon D. Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr. Opin. Neurobiol. 15 (2005) 257-265
77. Polo-Parada L., Bose C.M., and Landmesser L.T. Alterations in transmission, vesicle dynamics, and transmitter release machinery at NCAM-deficient neuromuscular junctions. Neuron, 32 (2001) 815-828
78. (2+) channel mutation. Brain 3 (2000) 463-471
79. 2+ currents blocked by the spider toxin omega-Aga-IVA. Neuroreport 5 (1993) 333-336
80. Raymond C., Walker D., Bichet D., Iborra C., Martin-Moutot N., Seagar M., and De Waard M. Antibodies against the beta subunit of voltage-dependent calcium channels in Lambert-Eaton myasthenic syndrome. Neuroscience 90 (1999) 269-277
81. Reuter H. Diversity and function of presynaptic calcium channels in the brain. Curr. Opin. Neurobiol. 6 (1996) 331-337
82. Rios E., and Pizarro G. Voltage sensor of excitation-contraction coupling in skeletal muscle. Physiol. Rev. 71 (1991) 849-908
83. Rosato-Siri M.D., and Uchitel O.D. Calcium channels coupled to neurotransmitter release at neonatal rat neuromuscular junctions. J. Physiol. (Lond.) 514 (1999) 533-540
84. 2+-dependence of transmitter release mediated by P/Q and N-type calcium channels at neonatal rat neuromuscular junctions. Eur. J. Neurosci. 15 (2002) 1874-1880
85. Santafé M.M., Lanuza M.A., Garcia N., and Tomàs J. Calcium inflow-dependent protein kinase C activity is involved in the modulation of transmitter release in the neuromuscular junction of the adult rat. Synapse 57 2 (2005) 76-84
86. Santafé M.M., Lanuza M.A., Garcia N., and Tomàs J. Muscarinic autoreceptors modulate transmitter release through protein kinase C and protein kinase A in the rat motor nerve terminal. Eur. J. Neurosci. 23 8 (2006) 2048-2056
87. Santafé M.M., Salon I., Garcia N., Lanuza M.A., Uchitel O.D., and Tomàs J. Modulation of ACh release by presynaptic muscarinic autoreceptors in the neuromuscular junction of the newborn and adult rat. Eur. J. Neurosci. 17 1 (2003) 119-127
88. Santafé M.M., Salon I., Garcia N., Lanuza M.A., Uchitel O.D., and Tomàs J. Muscarinic autoreceptors related with calcium channels in the strong and weak inputs at polyinnervated developing rat neuromuscular junctions. Neuroscience 123 1 (2004) 61-73
89. Santafé M.M., Urbano F.J., Lanuza M.A., and Uchitel O.D. Multiple types of calcium channels mediate transmitter release during functional recovery of botulinum toxin type A-poisoned mouse motor nerve terminals. Neuroscience 95 (2000) 227-234
90. Sheng Z.H., Rettig J., Takahashi M., and Catterall W.A. Identification of a syntaxin-binding site on N-type calcium channels. Neuron 13 (1994) 1303-1313
91. Singer D., Biel M., Lotan I., Flockerzi V., Hofmann F., and Dascal N. The roles of the subunits in the function of the calcium channel. Science 253 (1991) 1553-1557
92. Spafford J.D., and Zamponi G.W. Functional interactions between presynaptic calcium channels and the neurotransmitter release machinery. Curr. Opin. Neurobiol. 13 (2003) 308-314
93. Smith D.O., Conklin M.W., Jensen P.J., and Atchison W.D. Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome. J. Physiol. (Lond.) 15 (1995) 115-123
94. Sugiura Y., and Ko C.P. Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions. J. Neurosci. 17 (1997) 1101-1111
95. Takamori M., Hamada T., Komai K., Takahashi M., and Yoshida A. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Ann. Neurol. 35 1 (1994) 74-80
96. Takamori M., Komai K., and Iwasa K. Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome. Am. J. Med. Sci. 319 4 (2000) 204-208
97. Takamori M., Takahashi M., Yasukawa Y., Iwasa K., Remoto Y., Suenaga A., Nagataki S., and Nakamura T. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome. J. Neurol. Sci. 133 1-2 (1995) 95-101
98. Teng H., and Wilkinson R.S. Clathrin-mediated endocytosis near active zones in snake motor boutons. J. Neurosci. 20 (2000) 7986-7993
99. Uchitel O.D. Toxins affecting calcium channels in neurons. Toxicon 35 (1997) 1161-1191
100. Uchitel O.D., Protti D.A., Sanchez V., Cherksey B.D., Sugimori M., and Llinas R. P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3330-3333
101. 2+-buffer at mouse motor nerve terminals. Pflugers Arch. 437 (1999) 523-528
102. Urbano F.J., Depetris R.S., and Uchitel O.D. Coupling of L-type calcium channels to neurotransmitter release at mouse motor nerve terminals. Pflugers Arch. 441 (2001) 824-831
103. 2+ channels. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3491-3496
104. van den Maagdenberg A.M., Pietrobon D., Pizzorusso T., Kaja S., Broos L.A., Cesetti T., van de Ven R.C., Tottene A., van der Kaa J., Plomp J.J., Frants R.R., and Ferrari M.D. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41 5 (2004) 701-710
105. Verschuuren J.J., Dalmau J., Tunkel R., Lang B., Graus F., Schramm L., Posner J.B., Newsom-Davis J., and Rosenfeld M.R. Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome. Neurology 50 2 (1998) 475-479
106. Vincent A., Lang B., and Kleopa K.A. Autoimmune channelopathies and related neurological disorders. Neuron 52 (2006) 123-138 Review
107. 2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J. Neurosci. 18 (1998) 6319-6330
108. Xu Y.F., Hewett S.J., and Atchison W.D. Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of ICa in mouse motor nerve terminals. J. Neurophysiol. 80 (1998) 1056-1069
109. Zhuchenko O., Bailey J., Bonnen P., Ashizawa T., Stockton D.W., Amos C., Dobyns W.B., Subramony S.H., Zoghbi H.Y., and Lee C.C. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat. Genet. 15 1 (1997) 62-69